Literature DB >> 23228828

The ketogenic diet: metabolic influences on brain excitability and epilepsy.

Andrew Lutas1, Gary Yellen.   

Abstract

A dietary therapy for pediatric epilepsy known as the ketogenic diet has seen a revival in its clinical use during the past decade. Although the underlying mechanism of the diet remains unknown, modern scientific approaches, such as the genetic disruption of glucose metabolism, are allowing for more detailed questions to be addressed. Recent work indicates that several mechanisms may exist for the ketogenic diet, including disruption of glutamatergic synaptic transmission, inhibition of glycolysis, and activation of ATP-sensitive potassium channels. Here, we describe on-going work in these areas that is providing a better understanding of metabolic influences on brain excitability and epilepsy.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23228828      PMCID: PMC3534786          DOI: 10.1016/j.tins.2012.11.005

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  92 in total

1.  Dynamic activation of K(ATP) channels in rhythmically active neurons.

Authors:  M Haller; S L Mironov; A Karschin; D W Richter
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

2.  The effect of 2-deoxyglucose on the metabolism of glucose, fructose, and galactose by rat diaphragm.

Authors:  H I NAKADA; A N WICK
Journal:  J Biol Chem       Date:  1956-10       Impact factor: 5.157

Review 3.  Endogenous control of epilepsy: the nigral inhibitory system.

Authors:  A Depaulis; M Vergnes; C Marescaux
Journal:  Prog Neurobiol       Date:  1994-01       Impact factor: 11.685

4.  BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures.

Authors:  Alfredo Giménez-Cassina; Juan Ramón Martínez-François; Jill K Fisher; Benjamin Szlyk; Klaudia Polak; Jessica Wiwczar; Geoffrey R Tanner; Andrew Lutas; Gary Yellen; Nika N Danial
Journal:  Neuron       Date:  2012-05-24       Impact factor: 17.173

5.  Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo.

Authors:  Jong M Rho; Gail D Anderson; Sean D Donevan; H Steve White
Journal:  Epilepsia       Date:  2002-04       Impact factor: 5.864

6.  Lipid and fatty acid profiles in rats consuming different high-fat ketogenic diets.

Authors:  C A Dell; S S Likhodii; K Musa; M A Ryan; W M Burnham; S C Cunnane
Journal:  Lipids       Date:  2001-04       Impact factor: 1.880

Review 7.  Possible mechanisms for the anticonvulsant activity of fructose-1,6-diphosphate.

Authors:  Janet L Stringer; Kaiping Xu
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

8.  The ketogenic diet increases mitochondrial glutathione levels.

Authors:  Stuart G Jarrett; Julie B Milder; Li-Ping Liang; Manisha Patel
Journal:  J Neurochem       Date:  2008-05-05       Impact factor: 5.372

9.  The ketogenic diet increases mitochondrial uncoupling protein levels and activity.

Authors:  Patrick G Sullivan; Nancy A Rippy; Kristina Dorenbos; Rachele C Concepcion; Aakash K Agarwal; Jong M Rho
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

10.  Lactate Effectively Covers Energy Demands during Neuronal Network Activity in Neonatal Hippocampal Slices.

Authors:  Anton Ivanov; Marat Mukhtarov; Piotr Bregestovski; Yuri Zilberter
Journal:  Front Neuroenergetics       Date:  2011-05-06
View more
  84 in total

1.  Inter-relationships among diet, obesity and hippocampal-dependent cognitive function.

Authors:  T L Davidson; S L Hargrave; S E Swithers; C H Sample; X Fu; K P Kinzig; W Zheng
Journal:  Neuroscience       Date:  2013-08-30       Impact factor: 3.590

2.  Glycolytic inhibition by 2-deoxy-d-glucose abolishes both neuronal and network bursts in an in vitro seizure model.

Authors:  Li-Rong Shao; Carl E Stafstrom
Journal:  J Neurophysiol       Date:  2017-04-12       Impact factor: 2.714

Review 3.  New insights into the mechanisms of the ketogenic diet.

Authors:  Detlev Boison
Journal:  Curr Opin Neurol       Date:  2017-04       Impact factor: 5.710

Review 4.  Changing appetites: the adaptive advantages of fuel choice.

Authors:  Illana A Stanley; Sofia M Ribeiro; Alfredo Giménez-Cassina; Erik Norberg; Nika N Danial
Journal:  Trends Cell Biol       Date:  2013-09-07       Impact factor: 20.808

5.  Human and rodent temporal lobe epilepsy is characterized by changes in O-GlcNAc homeostasis that can be reversed to dampen epileptiform activity.

Authors:  Richard G Sánchez; R Ryley Parrish; Megan Rich; William M Webb; Roxanne M Lockhart; Kazuhito Nakao; Lara Ianov; Susan C Buckingham; Devin R Broadwater; Alistair Jenkins; Nihal C de Lanerolle; Mark Cunningham; Tore Eid; Kristen Riley; Farah D Lubin
Journal:  Neurobiol Dis       Date:  2019-01-06       Impact factor: 5.996

6.  Metabolism regulates the spontaneous firing of substantia nigra pars reticulata neurons via KATP and nonselective cation channels.

Authors:  Andrew Lutas; Lutz Birnbaumer; Gary Yellen
Journal:  J Neurosci       Date:  2014-12-03       Impact factor: 6.167

Review 7.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

8.  BAD knockout provides metabolic seizure resistance in a genetic model of epilepsy with sudden unexplained death in epilepsy.

Authors:  Jeannine Foley; Veronica Burnham; Meghan Tedoldi; Nika N Danial; Gary Yellen
Journal:  Epilepsia       Date:  2017-11-23       Impact factor: 5.864

Review 9.  Ketogenic diets, mitochondria, and neurological diseases.

Authors:  Lindsey B Gano; Manisha Patel; Jong M Rho
Journal:  J Lipid Res       Date:  2014-05-20       Impact factor: 5.922

10.  Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats.

Authors:  Theresa A Lusardi; Kiran K Akula; Shayla Q Coffman; David N Ruskin; Susan A Masino; Detlev Boison
Journal:  Neuropharmacology       Date:  2015-08-06       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.